count

Press Releases

May 28, 2020

Chimeron Bio and George Mason University’s National Center for Biodefense and Infectious Diseases Partner to Develop a Coronavirus (COVID-19) Vaccine using ChaESAR™ Technology

April 16, 2020

Chimeron Bio Appoints Eminent Virologist Dr. Jonathan Smith to its Scientific Advisory Board as it Initiates COVID-19 Vaccine Program

April 2, 2020

A Message from the CEO on the COVID-19 Initiative

March 17, 2020

Chimeron Bio Launches Vaccine Program for COVID-19

February 12, 2020

Chimeron Bio Announces Appointment of Dr. Dominique Gouty to its Scientific Advisory Board

October 22, 2019

Chimeron Bio Announces Appointment of Dr. Robert (Bob) Willette to its Scientific Advisory Board

September 6, 2019

Chimeron Bio Announces Appointment of Dr. Afshin Safavi to Chairman of the Board

Media Inquiries

Interested in learning more about Chimeron Bio’s novel technology and the work we are doing to develop first-in-class self-amplifying RNA therapeutics?

Reach out to us at contact@chimeronbio.com today.

Follow Us

Harnessing the Power of saRNA with ChaESAR

Chimeron Bio’s ChaESAR platform is enabling application of saRNA biology to treat multiple genetic disorders and diseases.

See How